Published in Biomaterials on February 02, 2010
The influence of stereolithographic scaffold architecture and composition on osteogenic signal expression with rat bone marrow stromal cells. Biomaterials (2011) 1.07
Osteochondral tissue regeneration through polymeric delivery of DNA encoding for the SOX trio and RUNX2. Acta Biomater (2014) 0.80
Radially and axially graded multizonal bone graft substitutes targeting critical-sized bone defects from polycaprolactone/hydroxyapatite/tricalcium phosphate. Tissue Eng Part A (2012) 0.78
Cellular transduction gradients via vapor-deposited polymer coatings. Biomaterials (2010) 0.76
In Vitro Behavior of Human Adipose Tissue-Derived Stem Cells on Poly(ε-caprolactone) Film for Bone Tissue Engineering Applications. Biomed Res Int (2015) 0.75
Engineering graded tissue interfaces. Proc Natl Acad Sci U S A (2008) 1.69
Controlled release systems for DNA delivery. Mol Ther (2004) 1.59
In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res (2003) 1.57
Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents. Proc Natl Acad Sci U S A (2005) 1.35
Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem (2000) 1.33
Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther (2005) 1.32
Biological approaches to bone regeneration by gene therapy. J Dent Res (2005) 1.32
Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Ther (2007) 1.30
Ablation of proliferating marrow with 5-fluorouracil allows partial purification of mesenchymal stem cells. Stem Cells (2006) 1.26
Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Hum Gene Ther (2002) 1.17
Gene therapy for bone regeneration. Curr Gene Ther (2005) 1.13
Reactive polymer coatings that "Click". Angew Chem Int Ed Engl (2006) 1.11
Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries. Circulation (2008) 1.10
Bone tissue engineering and repair by gene therapy. Front Biosci (2008) 1.07
Concise review: embryonic stem cells: a new tool to study osteoblast and osteoclast differentiation. Stem Cells (2006) 1.07
Reactive polymer coatings: a first step toward surface engineering of microfluidic devices. Anal Chem (2003) 1.06
Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp Cell Res (2004) 1.06
Virus-based gene therapy strategies for bone regeneration. Biomaterials (2006) 1.01
Development of adenovirus immobilization strategies for in situ gene therapy. J Gene Med (2008) 1.01
Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery. Virology (2002) 0.98
Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors. Biomacromolecules (2009) 0.98
Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants. Gene Ther (2004) 0.97
Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose--derived stem cells in vitro and in vivo. Calcif Tissue Int (2006) 0.96
Surface modification of confined microgeometries via vapor-deposited polymer coatings. J Am Chem Soc (2006) 0.95
Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev (2000) 0.95
Immobilization of gene vectors on polyurethane surfaces using a monoclonal antibody for localized gene delivery. J Gene Med (2006) 0.94
Retrovirus-associated heparan sulfate mediates immobilization and gene transfer on recombinant fibronectin. J Virol (2002) 0.94
Endovascular microcoil gene delivery using immobilized anti-adenovirus antibody for vector tethering. Stroke (2002) 0.92
Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres. Gene Ther (1999) 0.91
Colloids with high-definition surface structures. Proc Natl Acad Sci U S A (2007) 0.90
Extended release of adenovirus from polymer microspheres: potential use in gene therapy for brain tumors. Adv Drug Deliv Rev (1997) 0.86
The use of reactive polymer coatings to facilitate gene delivery from poly (epsilon-caprolactone) scaffolds. Biomaterials (2009) 0.85
Cbfb enhances the osteogenic differentiation of both human and mouse mesenchymal stem cells induced by Cbfa-1 via reducing its ubiquitination-mediated degradation. Stem Cells (2007) 0.85
Gene therapy: design and prospects for craniofacial regeneration. J Dent Res (2009) 0.83
Digoxigenin modification of adenovirus to spatially control gene delivery from chitosan surfaces. J Control Release (2009) 0.81
Development of a new photocrosslinkable biodegradable bioadhesive. Int J Pharm (2007) 0.79
Lectins and/or xyloglucans/alginate layers as supports for immobilization of dengue virus particles. Colloids Surf B Biointerfaces (2008) 0.77
Controlled release of insulin from plasma-irradiated sandwitch device using poly-DL-lactic acid. Biol Pharm Bull (1993) 0.77
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest (2011) 4.43
Physical approaches to biomaterial design. Nat Mater (2009) 4.01
Ultrastrong and stiff layered polymer nanocomposites. Science (2007) 3.40
Ameloblastin is a cell adhesion molecule required for maintaining the differentiation state of ameloblasts. J Cell Biol (2004) 3.00
Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol (2010) 2.89
Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials (2005) 2.66
Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med (2009) 2.51
Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res (2002) 2.48
Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol (2007) 2.44
Multicompartmental microcylinders. Angew Chem Int Ed Engl (2009) 2.19
Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem (2002) 2.14
BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun (2003) 1.97
Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res (2011) 1.94
Ultrasmall implantable composite microelectrodes with bioactive surfaces for chronic neural interfaces. Nat Mater (2012) 1.93
Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem (2005) 1.91
BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res (2006) 1.91
Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials (2006) 1.88
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest (2007) 1.87
Biphasic Janus particles with nanoscale anisotropy. Nat Mater (2005) 1.86
Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res (2004) 1.83
Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J (2005) 1.79
Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J Biol Chem (2007) 1.70
VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res (2006) 1.63
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun (2013) 1.61
Marrow fat and bone--new perspectives. J Clin Endocrinol Metab (2013) 1.60
Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem Cells (2008) 1.58
In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res (2003) 1.57
Fabrication of discontinuous surface patterns within microfluidic channels using photodefinable vapor-based polymer coatings. Anal Chem (2005) 1.54
Fat grafting for thermal injury: current state and future directions. J Burn Care Res (2013) 1.51
Density of the alveolar and basal bones of the maxilla and the mandible. Am J Orthod Dentofacial Orthop (2008) 1.48
Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood (2007) 1.48
Nanotopography influences adhesion, spreading, and self-renewal of human embryonic stem cells. ACS Nano (2012) 1.47
Erythropoietin couples hematopoiesis with bone formation. PLoS One (2010) 1.44
A transgenic animal model resembling amelogenesis imperfecta related to ameloblastin overexpression. J Biol Chem (2003) 1.42
Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J Biol Chem (2009) 1.41
Sliding mechanics with microscrew implant anchorage. Angle Orthod (2004) 1.39
Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng (2003) 1.39
Prospective identification and skeletal localization of cells capable of multilineage differentiation in vivo. Stem Cells Dev (2010) 1.38
Red blood cell-mimicking synthetic biomaterial particles. Proc Natl Acad Sci U S A (2009) 1.38
Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev (2009) 1.38
Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype. J Bone Miner Res (2002) 1.33
Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther (2005) 1.32
Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng (2002) 1.29
Physical aspects of cell culture substrates: topography, roughness, and elasticity. Small (2011) 1.26
Ablation of proliferating marrow with 5-fluorouracil allows partial purification of mesenchymal stem cells. Stem Cells (2006) 1.26
Cooperative interactions between RUNX2 and homeodomain protein-binding sites are critical for the osteoblast-specific expression of the bone sialoprotein gene. J Biol Chem (2005) 1.25
The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs (2008) 1.24
Mechanics regulates fate decisions of human embryonic stem cells. PLoS One (2012) 1.24
Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells (2010) 1.24
Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone. PLoS One (2009) 1.20
Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J Bone Miner Res (2012) 1.18
Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem (2004) 1.16
Parathyroid hormone increases activating transcription factor 4 expression and activity in osteoblasts: requirement for osteocalcin gene expression. Endocrinology (2008) 1.13
Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev Dyn (2005) 1.12
Fabrication of synthetic polymer coatings and their use in feeder-free culture of human embryonic stem cells. Nat Protoc (2011) 1.12
Erythropoietin mediated bone formation is regulated by mTOR signaling. J Cell Biochem (2012) 1.11
Reactive polymer coatings that "Click". Angew Chem Int Ed Engl (2006) 1.11
An in vivo model to study and manipulate the hematopoietic stem cell niche. Blood (2010) 1.11
Human and murine very small embryonic-like cells represent multipotent tissue progenitors, in vitro and in vivo. Stem Cells Dev (2014) 1.10
Physical and functional interactions between Runx2 and HIF-1α induce vascular endothelial growth factor gene expression. J Cell Biochem (2011) 1.10
BMP gene delivery for alveolar bone engineering at dental implant defects. Mol Ther (2005) 1.09
Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation. J Bone Miner Res (2013) 1.08
Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J Cell Biochem (2005) 1.07
Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. Am J Pathol (2011) 1.07
Proteomics and genetics of dental enamel. Cells Tissues Organs (2005) 1.07
Engineered osteochondral grafts using biphasic composite solid free-form fabricated scaffolds. Tissue Eng (2004) 1.07
Solventless adhesive bonding using reactive polymer coatings. Anal Chem (2008) 1.06
The insulation performance of reactive parylene films in implantable electronic devices. Biomaterials (2009) 1.06
Adipose tissue stem cells: the great WAT hope. Trends Endocrinol Metab (2012) 1.05
The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model. J Biomed Mater Res A (2010) 1.05
Human very small embryonic-like cells generate skeletal structures, in vivo. Stem Cells Dev (2012) 1.05
Nonextraction treatment with microscrew implants. Angle Orthod (2004) 1.04
Leptin does not directly affect CNS serotonin neurons to influence appetite. Cell Metab (2011) 1.04
Burn injury enhances bone formation in heterotopic ossification model. Ann Surg (2014) 1.03
Parathyroid hormone induction of the osteocalcin gene. Requirement for an osteoblast-specific element 1 sequence in the promoter and involvement of multiple-signaling pathways. J Biol Chem (2003) 1.02
Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol Ther (2004) 1.02
Effects of pH on human bone marrow stromal cells in vitro: implications for tissue engineering of bone. J Biomed Mater Res (2002) 1.02
Adenosine triphosphate hydrolysis reduces neutrophil infiltration and necrosis in partial-thickness scald burns in mice. J Burn Care Res (2014) 1.01
TBK1 regulates prostate cancer dormancy through mTOR inhibition. Neoplasia (2013) 1.01
Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering. Biomaterials (2005) 1.01
Development of adenovirus immobilization strategies for in situ gene therapy. J Gene Med (2008) 1.01
Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2. Bone (2010) 1.00
Artificial sweeteners stimulate adipogenesis and suppress lipolysis independently of sweet taste receptors. J Biol Chem (2013) 1.00
Connexin 43 as a signaling platform for increasing the volume and spatial distribution of regenerated tissue. Proc Natl Acad Sci U S A (2009) 0.99
Analysis of transcription factor interactions in osteoblasts using competitive chromatin immunoprecipitation. Nucleic Acids Res (2008) 0.99
Erythropoietin modulates the structure of bone morphogenetic protein 2-engineered cranial bone. Tissue Eng Part A (2012) 0.99
Epithelial interactions and local engraftment of lung-resident mesenchymal stem cells. Am J Respir Cell Mol Biol (2011) 0.98
Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone. Mol Cancer Ther (2008) 0.98
Biomechanical stimulation of osteoblast gene expression requires phosphorylation of the RUNX2 transcription factor. J Bone Miner Res (2012) 0.96
Determination of the fate and contribution of ex vivo expanded human bone marrow stem and progenitor cells for bone formation by 2.3ColGFP. Mol Ther (2009) 0.96
Expansion and characterization of human embryonic stem cell-derived osteoblast-like cells. Cell Reprogram (2010) 0.96
Surface modification of confined microgeometries via vapor-deposited polymer coatings. J Am Chem Soc (2006) 0.95
Differentiation-dependent association of phosphorylated extracellular signal-regulated kinase with the chromatin of osteoblast-related genes. J Bone Miner Res (2010) 0.95